| Symbol |
Name |
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
AGR2
|
anterior gradient 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
|
APC
|
adenomatous polyposis coli
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCND1
|
cyclin D1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDK5RAP1
|
CDK5 regulatory subunit associated protein 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CLU
|
clusterin
|
|
CRISP3
|
cysteine-rich secretory protein 3
|
|
CRY1
|
cryptochrome circadian clock 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
EDN1
|
endothelin 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF5A2
|
eukaryotic translation initiation factor 5A2
|
|
ENG
|
endoglin
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HK2
|
hexokinase 2
|
|
HMOX1
|
heme oxygenase 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL10
|
interleukin 10
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
INS
|
insulin
|
|
ISCU
|
iron-sulfur cluster assembly enzyme
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KLK11
|
kallikrein-related peptidase 11
|
|
KLK13
|
kallikrein-related peptidase 13
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
LGMN
|
legumain
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MB
|
myoglobin
|
|
MIR141
|
microRNA 141
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR215
|
microRNA 215
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPP5
|
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)
|
|
MSMB
|
microseminoprotein, beta-
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYOD1
|
myogenic differentiation 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX1
|
NADPH oxidase 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCDH10
|
protocadherin 10
|
|
PF4
|
platelet factor 4
|
|
PI16
|
peptidase inhibitor 16
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PITX2
|
paired-like homeodomain 2
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PON1
|
paraoxonase 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PSCA
|
prostate stem cell antigen
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
RABGEF1
|
RAB guanine nucleotide exchange factor (GEF) 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RHOC
|
ras homolog family member C
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RSAD2
|
radical S-adenosyl methionine domain containing 2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100P
|
S100 calcium binding protein P
|
|
SEMG1
|
semenogelin I
|
|
SEMG2
|
semenogelin II
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
STARD4
|
StAR-related lipid transfer (START) domain containing 4
|
|
SYK
|
spleen tyrosine kinase
|
|
TF
|
transferrin
|
|
TLR4
|
toll-like receptor 4
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TP53
|
tumor protein p53
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TRIM29
|
tripartite motif containing 29
|
|
TYMS
|
thymidylate synthetase
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UMOD
|
uromodulin
|
|
UMPS
|
uridine monophosphate synthetase
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
XDH
|
xanthine dehydrogenase
|
